Sara A Chacko1, Gloria Y Yeh2, Roger B Davis2, Christina C Wee2. 1. Division of General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States. Electronic address: sachacko@bidmc.harvard.edu. 2. Division of General Medicine and Primary Care, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, United States.
Abstract
OBJECTIVE: This study aimed to develop and test a novel mindfulness-based intervention (MBI) designed to control weight after bariatric surgery. DESIGN: Randomized, controlled pilot trial. SETTING: Beth Israel Deaconess Medical Center, Boston, MA, USA. INTERVENTIONS:Bariatric patients 1-5 yearspost-surgery (n=18) were randomized to receive a 10-week MBI or a standard intervention. MAIN OUTCOME MEASURES: Primary outcomes were feasibility and acceptability of the MBI. Secondary outcomes included changes in weight, eating behaviors, psychosocial outcomes, and metabolic and inflammatory biomarkers. Qualitative exit interviews were conducted post-intervention. Major themes were coded and extracted. RESULTS:Attendance was excellent (6 of 9 patients attended ≥7 of 10 classes). Patients reported high satisfaction and overall benefit of the MBI. The intervention was effective in reducing emotional eating at 6 months (-4.9±13.7 in mindfulness vs. 6.2±28.4 in standard, p for between-group difference=0.03) but not weight. We also observed a significant increase in HbA1C (0.34±0.38 vs. -0.06±0.31, p=0.03). Objective measures suggested trends of an increase in perceived stress and symptoms of depression, although patients reported reduced stress reactivity, improved eating behaviors, and a desire for continued mindfulness-based support in qualitative interviews. CONCLUSIONS: This novel mindfulness-based approach is highly acceptable to bariatric patients post-surgery and may be effective for reducing emotional eating, although it did not improve weight or glycemic control in the short term. Longer-term studies of mindfulness-based approaches may be warranted in this population. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02603601.
RCT Entities:
OBJECTIVE: This study aimed to develop and test a novel mindfulness-based intervention (MBI) designed to control weight after bariatric surgery. DESIGN: Randomized, controlled pilot trial. SETTING: Beth Israel Deaconess Medical Center, Boston, MA, USA. INTERVENTIONS: Bariatric patients 1-5 years post-surgery (n=18) were randomized to receive a 10-week MBI or a standard intervention. MAIN OUTCOME MEASURES: Primary outcomes were feasibility and acceptability of the MBI. Secondary outcomes included changes in weight, eating behaviors, psychosocial outcomes, and metabolic and inflammatory biomarkers. Qualitative exit interviews were conducted post-intervention. Major themes were coded and extracted. RESULTS: Attendance was excellent (6 of 9 patients attended ≥7 of 10 classes). Patients reported high satisfaction and overall benefit of the MBI. The intervention was effective in reducing emotional eating at 6 months (-4.9±13.7 in mindfulness vs. 6.2±28.4 in standard, p for between-group difference=0.03) but not weight. We also observed a significant increase in HbA1C (0.34±0.38 vs. -0.06±0.31, p=0.03). Objective measures suggested trends of an increase in perceived stress and symptoms of depression, although patients reported reduced stress reactivity, improved eating behaviors, and a desire for continued mindfulness-based support in qualitative interviews. CONCLUSIONS: This novel mindfulness-based approach is highly acceptable to bariatric patients post-surgery and may be effective for reducing emotional eating, although it did not improve weight or glycemic control in the short term. Longer-term studies of mindfulness-based approaches may be warranted in this population. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov identifier NCT02603601.
Authors: J F Sallis; W L Haskell; P D Wood; S P Fortmann; T Rogers; S N Blair; R S Paffenbarger Journal: Am J Epidemiol Date: 1985-01 Impact factor: 4.897
Authors: Madhav Goyal; Sonal Singh; Erica M S Sibinga; Neda F Gould; Anastasia Rowland-Seymour; Ritu Sharma; Zackary Berger; Dana Sleicher; David D Maron; Hasan M Shihab; Padmini D Ranasinghe; Shauna Linn; Shonali Saha; Eric B Bass; Jennifer A Haythornthwaite Journal: JAMA Intern Med Date: 2014-03 Impact factor: 21.873
Authors: Jeanne Dalen; Bruce W Smith; Brian M Shelley; Anita Lee Sloan; Lisa Leahigh; Debbie Begay Journal: Complement Ther Med Date: 2010-11-11 Impact factor: 2.446
Authors: Jacqueline Odom; Kerstyn C Zalesin; Tamika L Washington; Wendy W Miller; Basil Hakmeh; Danielle L Zaremba; Mohamed Altattan; Mamtha Balasubramaniam; Deborah S Gibbs; Kevin R Krause; David L Chengelis; Barry A Franklin; Peter A McCullough Journal: Obes Surg Date: 2009-06-25 Impact factor: 4.129
Authors: Emma Chad-Friedman; Melanie Pearsall; Kathleen M Miller; Amy E Wheeler; John W Denninger; Darshan H Mehta; Michelle L Dossett Journal: Glob Adv Health Med Date: 2018-07-04